Biotec Services International, the global provider of temperature controlled packaging and distribution services for clinical trials, is doubling its capacity with the addition of new processing facilities, following impressive growth.
The Bridgend-headquartered company is expanding into additional operational, packaging and storage facilities on the back of 15 per cent growth in the last year.
As a result of increased client demand and significant contract wins, Biotec Services is increasing its controlled room temperature storage by 100 per cent and its cold room storage by 400 per cent. It is also creating a second advanced therapeutic medicinal products (ATMP) facility.
Providing support to hundreds of clinical trial and commercial projects for clients across the world, Biotec Services has built an impressive reputation for its cold chain packaging and distribution services across a full temperature range from controlled ambient down to minus 196°C.
Dr Fiona Withey, Chief Executive Officer of Biotec Services, said: “We have an exciting pipeline of work and an increasing number of phase III trials with larger storage requirements, which has resulted in a need to expand our temperature controlled packaging and storage facilities.
“Feedback from our recent client survey indicated that refrigerated storage at +2°C to +8°C is the range that most suits our partners’ requirements so we are developing our facilities in line with this and also bespoke temperature demands.
“The investment, which was secured with the help of Business Manager, Brent Arthur of Allied Irish Bank in Cardiff, demonstrates our continued commitment to developing innovative solutions to meet our clients’ clinical supplies requirements.”
Mr Arthur, said “Biotec Services International has an inspirational management team with clear long term objectives and we are delighted to be involved with their future growth plans.”
As part of the company’s strategic growth plans, with advice from commercial property agents DTZ it has also acquired land adjacent to the current Biotec Services’ facilities from Herbert R Thomas, acting on behalf of Robert Hitchins, which will be developed in-line with client demands.
Dr Withey, continued: “We have ambitious objectives for the next three years as we move towards achieving our vision of becoming the market leader in cold chain clinical trial services, headquartered in the UK with a global presence. We will be looking to continue to develop our services for existing customers and to grow more and more partnerships worldwide, tackling new markets. With these plans in mind, we have secured land adjoining our current facilities to accommodate our future growth.”
Led by CEO Dr Fiona Withey, Biotec Services International was established in 1997 and is now a leading global provider of temperature controlled clinical trial services including import, QP certification, labelling, assembly, storage and distribution of clinical trial supplies. The company operates from a purpose-built GMP facility licensed by the MHRA. It works with a global client base ranging from virtual companies to blue chip international pharmaceutical and healthcare companies to conduct trials from Phase I to Phase IV.